Skip to main content

Tm Bioscience Hires Distributor to Sell ID-Tag Respiratory Panel in Netherlands

NEW YORK, June 16 (GenomeWeb News) - Tm Bioscience today said that Dutch distributor Sanbio will commercialize its ID-Tag Respiratory Viral Panel in the Netherlands, which is Tm's first deal of its kind in Europe.

 

The panel detects and discriminates between 20 respiratory viruses including Avian Flu and SARS, Tm said. Terms of the agreement give Sanbio exclusive right to market and sell the panel in the Netherlands. Tm will supply the distributor with finished packaged product and will receive revenue from the sales.

Tm "intend[s] to complete a series of distribution agreements across Europe over the coming months to be well positioned for the rapid commercialization of this test upon gaining European regulatory clearance, which we anticipate will be achieved in 2006," Tm President and CEO Greg Hines said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.